Cite
HARVARD Citation
Yang, S. et al. (2019). Long-acting muscarinic antagonist versus long-acting β2 agonist/corticosteroid for moderate to severe chronic obstructive pulmonary disease patients. Journal of the Chinese Medical Association. 82 (6), p. . [Online].